期刊文献+

弥漫性肺疾病70例临床报道 被引量:6

Clinical report of diffuse parenchymal lung disease:70 cases
下载PDF
导出
摘要 目的 分析十堰地区2015~2018年弥漫性肺疾病(DPLD)的诊断与治疗情况。方法 回顾性选取2015年1月~2018年12月在十堰市太和医院住院治疗的70例DPLD患者,年龄20~79岁,平均(52.59±14.61)岁。分析其临床、影像、病理检查等结果与治疗情况。结果 70例DPLD中非特异性间质性肺炎是主要病理类型。患者临床表现以咳嗽、活动后呼吸困难、进行性气短、发热等为主,体征主要表现为发钳、肺部闻及Velcro啰音、湿罗音等;胸部X射线检查以网状影、斑片影、结节状阴影较常见,且以弥散分布为主,累及双侧肺野;胸部CT检查结果显示,病灶累及双侧肺野,以双侧中下肺为主,以斑片状影、网格状影、胸膜肥厚为主;血常规检查以血沉升高、中性粒细胞计数升高、C反应蛋白升高为主。70例患者中有48例接受肺功能检查,83.33%(40/48)的患者检出限制性通气功能障碍。病理检查前有23例接受抗感染治疗,14例接受糖皮质激素治疗。病理确诊后,60例接受抗感染治疗,使用激素者40例,抗感染联合激素治疗者34例,抗感染、激素联合免疫抑制剂者7例。70例患者中无放弃治疗者,在治疗1个月内死亡1例。结论 DPLD好发于中老年人群,以进行性加重的呼吸困难、咳嗽为主要症状,肺部可闻及Velcro啰音,疾病多为明确病因的DPLD,糖皮质激素或(和)免疫抑制剂是其主要治疗手段,患者一般预后良好,死亡率低。 Objective To explore the diagnosis and treatment of diffuse parenchymal lung disease(DPLD)in Shiyan area from 2015 to 2018.Methods The retrospective analysis was adopted.70 cases of DPLD patients hospitalized from January 2015 to December 2018 in Shiyan area were enrolled.The general data of patients were carefully consulted,the situations of diagnosis and treatment were analyzed.Results 70 patients with DPLD were diagnosed by clinical-imaging-pathology.Non-specific interstitial pneumonia was the main pathological type.The clinical manifestations of patients with DPLD included cough,difficult breathing after exercise,shortness of breath,fever,etc.,the main signs were cyanosis,Velcro rale,moist rale,etc.;Chest X-ray examination was more common with reticular shadow,patchy shadow,nodular shadow,and they diffusely distributed,involving both lung fields;Chest CT examination revealed that the lesions involved bilateral lung fields,mainly bilateral middle and lower lungs,with patchy shadow,grid-like shadow and pleural thickening;Blood routine examination showed elevated erythrocyte sedimentation rate,elevated neutrophil count and elevated C-reactive protein;48 cases of the 70 patients underwent pulmonary function examination,,and restrictive ventilatory dysfunction was detected in 83.33%(40/48)of patients.Before pathological examination,23 patients received anti-infective treatment and 14 patients received glucocorticoid therapy.After pathological diagnosis,60 patients received anti-infective treatment,40 patients used hormones,34 patients took anti-infective combined with hormone therapy,and 7 patients received anti-infective,hormone combined with immunosuppressive agents.Among the 70 patients who did not give up treatment,1 cases died within 1 month of treatment.Conclusion DPLD occurs in the middle-aged and elderly population.The main symptoms are cough and dyspnea with progressive aggravation.The lung Velcro rale possibly indicates the connective tissue disease(CTD)-related lung disease and idiopathic pulmonary fibrosis(IPF).and is mainly caused by infectious diseases and CTD-related lung diseases.The glucocorticoids or(and)immunosuppressive agent are the main treatment methods,and the patients generally have a good prognosis and low mortality rate.
作者 任涛 唐以军 王梅芳 钱鑫 周妍卉 Ren Tao;Tang Yijun;Wang Meifang(Department of Respiratory and Critical Care Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,China)
出处 《中华保健医学杂志》 2019年第6期535-538,共4页 Chinese Journal of Health Care and Medicine
基金 湖北省十堰市肺癌流行病调查研究(ZD201314)
关键词 弥漫性肺疾病 十堰地区 流行病学调查 Diffuse parenchymal lung disease Shiyan area Epidemiological investigation
  • 相关文献

参考文献7

二级参考文献44

  • 1American Thoracic Society/ European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med,2002,165:277-304.
  • 2Nicholson AG, Colby TV, du Bois RM, et al. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med, 2000,162 : 2213-2217.
  • 3Collard HR, Ryu JH, DouglasW W, et al. Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis. Chest, 2004,125 : 2169-2174.
  • 4Douglas WW, Ryu JH, Schroeder DR. Idiopathic pulmonary fibrosis:impact of oxygen and colchicines, prednisone, or no therapy on survival. Am J Respir Crit Care Med, 2000,161(4 Pt1) :1172-1178.
  • 5Joseph AL,Luis AO. Antifibrotic therapy for the treatment of pulmonary fibrosis. Am J Med Sci,2001,322:213-221.
  • 6管守隆,吾妻安良太,阿部庄作,等.特发性间质性肺炎慢性型にぉけるPirfenidoneの临床成绩.日呼吸会誌,2002,40(增刊):148—150.
  • 7Azuma A, Nukiwa T, Tsuboi E, et al. Double blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2005, 171.-1040-1047.
  • 8Ziesche R, Hofbarer E,Wittmannn K, et al. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med, 1999,341 : 1264-1269.
  • 9Raghu G,Brown KK, Bradford WZ, et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med,2004,350:125-133.
  • 10Karla S, Utz JP, Ryu JH. Interferon gamma-1b therapy for advanced idiopathic pulmonary fibrosis. Mayo Clinic Interstitial Lung Diseases Group. Mayo Clin Proc, 2003,78:1082-1087.

共引文献61

同被引文献41

引证文献6

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部